|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 44, Issue 3 133-135, Copyright © 1994 by American Cancer Society
F. Mitelman
For over 100 years, scientists have been investigating the role of genetic
change in neoplasia. Dr. Felix Mitelman, a Professor in the Department of
Clinical Genetics at the University Hospital in Lund, Sweden, describes the
progression in thought and technology that has led to the identification
and characterization of genetic changes leading to cancer at a chromosomal
and molecular level.
EDITORIALS
Chromosomes, genes, and cancer
This article has been cited by other articles:
![]() |
A. Thakur, K. W. Rahman, J. Wu, A. Bollig, H. Biliran, X. Lin, H. Nassar, D. J. Grignon, F. H. Sarkar, and J. D. Liao Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer Mol. Cancer Res., February 1, 2007; 5(2): 171 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Le Hegarat, L. Puech, V. Fessard, J. M. Poul, and S. Dragacci Aneugenic potential of okadaic acid revealed by the micronucleus assay combined with the FISH technique in CHO-K1 cells Mutagenesis, May 1, 2003; 18(3): 293 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Kutler, A. D. Auerbach, J. Satagopan, P. F. Giampietro, S. D. Batish, A. G. Huvos, A. Goberdhan, J. P. Shah, and B. Singh High Incidence of Head and Neck Squamous Cell Carcinoma in Patients With Fanconi Anemia Arch Otolaryngol Head Neck Surg, January 1, 2003; 129(1): 106 - 112. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |